Orally absorbable D-forphenicinol-cephalosporins

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Cephalosporins are a vital class of beta-lactam antibiotics.
• Developing orally active cephalosporins with broad-spectrum activity remains a key challenge.
• Novel side chains can modulate antibacterial spectrum and pharmacokinetic properties.

Purpose of the Study:

• To synthesize and biologically evaluate novel D-forphenicinol-cephalosporin derivatives.
• To explore the structure-activity relationships of these new compounds.
• To identify lead compounds with promising antibacterial and pharmacokinetic profiles.

Main Methods:

• Synthesis of 7-amino-3-(substituted)-3-cephem-4-carboxylic acid esters.
• Coupling of cephalosporin esters with N-tert-butoxy-carbonyl-D-forphenicinol derivatives.
• In vitro antibacterial activity assays and in vivo oral absorption studies in mice.

Main Results:

• Successful synthesis of a series of D-forphenicinol-cephalosporin analogs.
• Most synthesized analogs demonstrated significant in vitro antibacterial activity.
• Several compounds exhibited good gastrointestinal absorption in murine models.
• The 7-(mono-O-methyl-D-forphenicinol)-3-propenyl analog displayed the most potent biological activity.

Conclusions:

• D-forphenicinol-cephalosporins represent a promising class of novel antibiotics.
• The developed analogs possess favorable antibacterial properties and oral bioavailability.
• Further investigation of the lead compound is warranted for potential therapeutic applications.